205 related articles for article (PubMed ID: 26683602)
1. Association of C609T-Inborn Polymorphism of NAD(P)H: Quinone Oxidoreductase 1 with the Risk of Bronchopulmonary Dysplasia in Preterm Neonates.
Gavrili S; Zachaki S; Daraki A; Polycarpou E; Manola K; Stavropoulou C; Sambani C; Baroutis G
Am J Perinatol; 2016 May; 33(6):535-9. PubMed ID: 26683602
[TBL] [Abstract][Full Text] [Related]
2. GSTP1 and CYP2B6 Genetic Polymorphisms and the Risk of Bronchopulmonary Dysplasia in Preterm Neonates.
Zachaki S; Daraki A; Polycarpou E; Stavropoulou C; Manola KN; Gavrili S
Am J Perinatol; 2017 Jul; 34(8):729-734. PubMed ID: 28081574
[No Abstract] [Full Text] [Related]
3. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
4. TNF-238 polymorphism may predict bronchopulmonary dysplasia among preterm infants in the Egyptian population.
Elhawary NA; Tayeb MT; Abdel-Ghafar S; Rashad M; Alkhotani AA
Pediatr Pulmonol; 2013 Jul; 48(7):699-706. PubMed ID: 23359489
[TBL] [Abstract][Full Text] [Related]
5. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
7. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants.
Kazzi SN; Kim UO; Quasney MW; Buhimschi I
Pediatrics; 2004 Aug; 114(2):e243-8. PubMed ID: 15286263
[TBL] [Abstract][Full Text] [Related]
9. No association of urokinase gene 3'-UTR polymorphism with bronchopulmonary dysplasia for ventilated preterm infants.
Lin HC; Su BH; Lin TW; Hsu CM; Wan L; Tsai CH; Tsai FJ
Acta Paediatr Taiwan; 2004; 45(6):315-9. PubMed ID: 15868845
[TBL] [Abstract][Full Text] [Related]
10. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
Siegel D; McGuinness SM; Winski SL; Ross D
Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
13. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
14. Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues.
Tseng LM; Yin PH; Tsai YF; Chi CW; Wu CW; Lee LM; Lee HC
Oncol Rep; 2009 May; 21(5):1169-74. PubMed ID: 19360290
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
[TBL] [Abstract][Full Text] [Related]
18. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
Malik MA; Zargar SA; Mittal B
DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
[TBL] [Abstract][Full Text] [Related]
19. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
